Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPEP | Q07075 | 7/20 | 0.43 |
| ▸ | BACE1 | P56817 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | FNTA | P49354 | 5/20 | 0.40 |
| ▸ | FNTB | P49356 | 5/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30051929 | 0.93 | ENPEP (0.44) | ENPEPALDH1A1FNTAFNTBL3MBTL1 | |
| SCHEMBL13154778 | 0.91 | ENPEP (0.49) | ENPEPALDH1A1FNTAFNTBL3MBTL1 | |
| SCHEMBL14941274 | 0.91 | ENPEP (0.49) | ENPEPALDH1A1FNTAFNTBL3MBTL1 | |
| SCHEMBL14941273 | 0.91 | ENPEP (0.49) | ENPEPALDH1A1FNTAFNTBL3MBTL1 | |
| SCHEMBL30053260 | 0.89 | FOLH1 (0.42) | ENPEPBACE1ALDH1A1FNTAFNTB | |
| SCHEMBL29527825 | 0.89 | FNTA (0.46) | BACE1FNTAFNTBPGGT1B | |
| SCHEMBL30051191 | 0.89 | ENPEP (0.47) | ENPEPALDH1A1L3MBTL1 | |
| SCHEMBL29865508 | 0.87 | BACE1 (0.48) | ENPEPBACE1 | |
| SCHEMBL29391346 | 0.87 | CTSD (0.44) | ENPEPBACE1FNTAFNTB | |
| SCHEMBL30051938 | 0.86 | ENPEP (0.45) | ENPEPBACE1ALDH1A1FNTAFNTB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025085916-A1 | HUMANIZED MONOCLONAL ANTIBODY AND VACCINES AGAINST MEASLES VIRUS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2025-04-24 | — | — | WO | disclosed |